CHARLES RIVER LABORATORIES INTERNATIONAL INC (CRL)
@CRL.asset
$178.86
At close:
Charles River Laboratories International Inc is a pharmaceutical company providing drug discovery and development services. The company provides animal models for laboratory testing, and offers manufacturing testing services to various industries.
Figures
- Sector Healthcare
- Industry Medical Diagnostics & Research
- Index S&P 500
- Market Cap $8.80 B
- Last Earnings Report Aug 6, 2025
- Price Reaction to Earnings Report -12.36%
- Enterprise Value $11.00 B
- P/E ratio -130.71
- Price/Sales ratio 2.25
- EV/Sales ratio 2.73
- Price/Book Value 2.66
- Revenue $4.03 B
- EBIT $0.31 B
- Net Income $-0.07 B
- Gross Profit $1.31 B
- Free Cash Flow $0.60 B
- EBIT Margin 7.63%
- Gross Margin 32.47%
- FCF Margin 14.79%
- Return on Equity -2.04%
- Equity Ratio 44.96%
- Debt/Equity Ratio 1.22
- 6-month Performance 49.75%
- 12-month Performance -1.16%
- Trend reversal good
What the community is saying
| Nobody said anything, yet! Speak your mind and be the first to create a new topic. |